Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2003-08-01
Original market date: See footnote 1
1973-12-31
Product name:
TRANXENE CAP 3.75MG
DIN:
00264938 Electronic product monograph is not available
Company:
ABBOTT LABORATORIES, LIMITED
8401 Trans-Canada Highway
Saint-Laurent
Quebec
Canada
H4S 1Z1
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Targeted (CDSA IV)
American Hospital Formulary Service (AHFS): See footnote 3
28:24.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05BA05 CLORAZEPATE POTASSIUM
Active ingredient group (AIG) number:See footnote5
0108895001
Active ingredient(s) | Strength |
---|---|
CLORAZEPATE DIPOTASSIUM | 3.75 MG |